Altitude Flashcards
Naejji et al (2010)
Sitaxsentan (endothelia antagonist) reduces pulmonary artery pressure at altitude and reduces the decrease in VO2 max.
Cohen and Small (1998)
Colonisation of high altitude of humans is late and limited - implications in evolutionary adaption to altitude
Schuler et al (2010)
Mouse study - showed that optimal haematocrit is higher than the physiological level. Gives capacity for increase with altitude, training etc
M.P. Fitzgerald (1914)
Pikes peak expedition, haematocrit increases with altitude
Hall (1937)
High altitude mammals such as the Llama do not have increased haematocrit compared to low land mammals
Beall et al (1998)
Tibetans don’t have increased haematocrit compared to low landers
Beall et al (2010)
GWAS study: shows that low haemoglobin level in Tibetans arises from HIF-2 genetic locus
Smith, Talbot et al (2009)
Cerro de Pasco, Peru. Participants taken to high altitude from Lima. Intravenous iron infusion reduced the increase in pulmonary artery pressure with altitude.
Iron is involved in HIF degradation pathway -> increased iron = reduced HIF levels.
Hodson et al (2016) 2 points
- HIF-2 inactivation, not HIF-1, inhibits ventilatory acclimation to altitude
- Phd inactivation increases the ventilatory response to hypoxia
Chuvash Polychythemia response to hypoxia
Increased ventilatory, HPV and increase in haematocrit response to hypoxia.
This occurs due to VHL mutation which is involved in HIF degradation and thus there is increased HIF signalling.
Kellenberg et al (2008)
Used MRI imaging to show that microbleeds occur in HACE.
Grunig et al (1997)
Measured hypoxic pulmonary vasoconstriction (HPV) response in individuals susceptible to HAPE and those not susceptible to HAPE. Individuals that are susceptible to HAPE have a stronger HPV response to hypoxia.
Luks et al (2017)
Used CT scans to show characteristic patchy pulmonary oedema in HAPE,
West et al (1992)
Stress failure of capillaries in HAPE. Measured by the detection of the presence of albumin in alveoli.
Sartori et al (1999)
Endothelin upregulated in HAPE susceptible climbers